Entry Rationale
Considered entry as strong earnings accompanied by a trading volume 3.75 times the 20-day average confirmed an attempt to break through the resistance level.
CRYO-CELL International GAAP EPS of $0.16 beats by $0.13, revenue of $7.82M beats by $0.37M
CRYO-CELL International reported earnings with both GAAP EPS and revenue exceeding expectations.
Considered entry as strong earnings accompanied by a trading volume 3.75 times the 20-day average confirmed an attempt to break through the resistance level.
Enter at the current price of $4.36, take profit when reaching the 20-day resistance level of $4.72, and cut losses if it breaks below the support level of $3.42.
RSI(14) is at a neutral level of 46.4, with the volume surging 3.75 times the 20-day average amid a bullish moving average alignment, and the volatility over the past 7 days recorded at +3.0%.
Entered in anticipation of breaking the resistance line ($4.72) driven by favorable earnings and trading volume surging to 3.75 times the 20-day average, but the actual result ended as a FAILED trade with a -16.3% decline toward the stop-loss line ($3.42). Looking at the candlestick pattern, it is regrettable that we failed to exercise sufficient prior caution regarding the significant expansion in volatility and mounting downward pressure on October 15, which recorded an open of 4.05, a high of 4.46, a low of 3.65, and a close of 3.65.
Even when accompanied by a surge in trading volume and favorable earnings, a stricter stop-loss criteria must be applied more conservatively at the point where the stock price breaks below the support line. In the next trade, risk will be managed by more strictly monitoring volatility and selling pressure near the support line.